CDC overrides advisory panel to back Pfizer booster for Americans with high-risk jobs
CDC advisory panel had only recommended boosters for elderly and some people with underlying medical conditions
The US Centers for Disease Control and Prevention has broken with advice from its own internal advisory panel to back a booster shot of the Pfizer and BioNTech Covid-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and adults in high-risk working and institutional settings.
The move came on Friday one day after an advisory panel to the agency did not recommend that people in high-risk jobs, such as teachers, and risky living conditions should get boosters. The panel had only recommended boosters for elderly and some people with underlying medical conditions.
Read the original article at The Guardian